A review of maternal and fetal growth factors in diabetic pregnancy

Current Diabetes Reviews

Volumn 6, Issue 2, 2010, Pages 116-125

  Higgins, Mary ^a   Auliffe, Fionnuala Mc ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b NONE

Author keywords

Diabetes; Foetal; Growth factors; Maternal; Pregnancy

Indexed keywords

ADIPONECTIN; CONNECTIVE TISSUE GROWTH FACTOR; GROWTH FACTOR; GROWTH HORMONE; INSULIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN RELATED PROTEIN 1; LEPTIN; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; PLACENTAL GROWTH FACTOR; RESISTIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; UNCLASSIFIED DRUG;

FETUS GROWTH; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROSOMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

ADULT; BIRTH WEIGHT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; FETUS; GROWTH HORMONE; HUMANS; HYPERGLYCEMIA; INFANT; INSULIN; LEPTIN; PLACENTAL HORMONES; PREGNANCY; PREGNANCY IN DIABETICS; RESISTIN;

EID: 77950815403     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339910790909431     Document Type: Review

References (142)

1. Confidential Enquiry into Maternal and Child Health. Pregnancy in women with Type 1 and Type 2 Diabetes in 2002-2003. England, Wales and Northern Ireland. CEMACH, London, 2005.
2. Corrigan N, Brazil DP, Mc Auliffe F. Fetal cardiac effects of maternal hyperglycaemis during pregnancy. Birth Defects Res A Clin Mol Teratol 2009 [epub ahead of print]
3. Russell N, Foley M, Kinsley B, Firth R, Coffey M, Mc Auliffe FM. Effects of pre-gestational diabetes on fetal cardiac function and structure. Am J Obstet Gynecol 2008; 199: 312-314
4. Russell N, Holloway P, Quinn S, et al. Cardiomyopathy and cardiomegaly in stillborn infants of diabetic mothers. Pediatr Dev Pathol 2008; 11: 10-14
5. Hare J. The Priscilla White Legacy. Textbook of Diabetes and Pregnancy. London: Martin Dunitz 2003; 13-22.
6. Evers IM, Bos AM, Aalders AL, van Ballegoole E, et al. Pregnancy in women with diabetes mellitus type 1: maternal and perinatal complications in spite of good glucose control. Ned Tijdschr Geeeskd 2000; 144: 804-809
7. White P. Diabetes in pregnancy. The treatment of diabetes mellitus. 4th Ed: Lea and Febiger 1928: 861-872
8. Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH. Macrosomia despite good glycaemic control in Type 1 Diabetic pregnancy: result of a nationawide study in the Netherlands. Diabetologia 2002; 45: 1484-1489
9. Higgins MF, Russell NM, Mulcahy CH, Coffey M, Foley ME, Mc Auliffe FM. Fetal anterior abdominal wall measurement in diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol 2008; 40: 43-47
10. McAuliffe F, Foley M, Firth R, Drury I, Stronge IM. Outcome of diabetic pregnancy with spontaneous labour after 38 weeks. Ir J Med Sci 1999; 168: 160-163
11. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with Type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004; 328: 915.
12. Langer O. Fetal macrosomia: etiologic factors. Clin Obstet Gynecol 2000; 43: 282-297
13. Small M, Cameron A, Lunan CB, Mac Cuish AC. Macrosomia in pregnancy compicated by insulin dependent diabetes mellitus. Diabetes Care 1987; 10: 594-599
14. Anna V, Vander Ploeg HP, Cheung NW, Huxley RR, Bauman AE. Socioeconomic correlation of the increasing trend in prevalence of gestational diabetes in large population of women between 1995-2005 Diabetes Care 2008; 31: 2288-2293
15. Gold AE, Reilly R, Little J, Walker JD. The effect of glycaemic control in the pre-gestational period and early pregnancy on birth weight in women with IDDM. Diabetes Care 1998; 21: 535-538
16. Johnstone FD, Mao J, Steel JM, Prescott RJ, Hume R. Factors affecting fetal weight distribution in women with Type 1 diabetes. BJOG 2000; 107: 1001-1006
17. Jovanovic-Peterson L, Peterson CM, Reed GF, Metzger BE, Mills JR, Knop RH. Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study. AJOG 1991; 164: 103-111
18. Di Piro JT, Talbert R, Yee GC, Matzke GR, Wells BG, Posey M. Gynaecologic disorders. In: Pharmacotherapy. 7th edition, Mc Graw Medical, Pp. 1298, 1998.
19. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Straus JF. Purification, characterisation and in vitro differenciation of cytotrophoblasts from human term placentae. Endocrinology 1986; 118: 1567-1582
20. Fuglsang J, Lauszus F, Flyvbjerg A, Ovesen P. Human placental growth hormone, insulin like growth factor I and II, and insulin requirements during Pregnancy in type 1 diabetes. J Clin Endocrinol Metab 2003; 88: 4355-4361
21. Mirlesse V, Fankenne F, Alsat E, Poncelet M, Hennen G, Evian-Brion D. Placental growth hormone in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr Res 1993; 34: 439-442
22. Verhaeghe J, Van Herck E, Hennen G, Foidart J, Igout A. Placental GH, IGF-I, IGF binding protein 1 and leptin during a glucose challenge test in pregnant women: relation to maternal body weight, glucose tolerance and birth weight. J Clin Endocrinol Metab 2002; 87: 2875-2882
23. Lacroix M, Guibourdenche J, Frendo JL, Muller F, Evian-Brion D. Human placental growth hormone. A review. Placenta 2002; 23: S87-S94.
24. Caufriez A, Franketine F, Englert Y, et al. Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol 1990; 258: E1014-E9.
25. Chellakooty M, Skibsted L, Skouby SO, et al. Longitudinal study of serum placental GH in 455 normal pregnancies: correlation to gestational age, fetal gender, and weight. J Clin Endocrinol Metab 2002; 87: 2734-2739
26. McIntyre HD, Serek R, Crane DI, et al. Placental growth hormone (PGH), GH binding protein, and insulin like growth factor axis in normal, growth-retarded and diabetic pregnancies: Correlation with fetal growth. J Clin Endocrinol Metab 2000; 85: 1143-1150
27. de Zegher F, Vanderschvenen-Lodeweyckx M, Spitz B, et al. Perinatal growth hormone physiology: effect of GH releasing factor on maternal and fetal secretion of pituitary and placental GH. J Clin Endocrinol Metab 1990; 71: 520-522
28. Patel N, Alsat E, Igout A, et al. Glucose inhibits placental GH secretion in vitro. J Clin Endocronol Metab 1995; 80: 1743-1746
29. Alsat E, Guibourdenche J, Couturier A, Evian-Brion D. Physiological role of human placental growth hormone. Mol Cell Endocrinol 1998; 140: 121-127
30. Mittal P, Espinoza J, Hassan S, et al. Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia. J Mat Fetal Neonatal Med 2007; 20: 651-659
31. Hu L, Lytras A, Bock ME, Yuen CK, Dodd JG, Cattini PA. Detection of placental growth hormone cariant and chorionic sommatotrophin L RNA expression in normal and diabetic pregnancy by reverse transcriptase polymerase chain reaction. Mol Cell Endocrinol 1999; 157: 131-142
32. Powell BL, Hollingshead P, Warburton P, et al. IGF-I is required for normal embryonic growth in mice. Genes Dev 1993; 7: 2609-2617
33. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin like growth factor 1 (IGF-I) and type 1 IGF receptor (IGF-Ir). Cell 1993; 75: 59-72.
34. Liu L, Harding JE, Evand PC, Gluckman PD. Maternal insulin like growth factor 1 infusion alters feto-placental carbohydrate and protein metabolism in pregnant sheep. Endocrinology 1994; 135: 895-900. (Pubitemid 24271177)
35. Lee PD, Giudice LC, Conover CA, Powell DR. Insulin like growth factor binding protein 1: recent findings and new directions. ProcSoc Exp Biol Med 1997; 216: 319-357
36. Gibson M, Alpin JD, White A, Westwood M. Regulation of IGF bioavailability in pregnancy. Mol Hum Reprod 2001; 7: 79-87.
37. Drop SL, Kortleve DJ, Guyda HJ, Posner BI. Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal and adult sera. J Clin Endocrinol Met 1984; 59: 908-915
38. Rajaram S, Baylink DJ, Mohan S. Insulin like growth factors in serum and other biological fluids: regulation and functions. Endocr Rev 1997; 1: 801-831
39. Sara VR, Hall K. Insulin like growth factors and their binding proteins. Physiol Rev 1990; 70: 591-614.
40. Turkalj I, Keller U, Ninnis R, Vosmeer S, Stauffacher W. Effect of incresing doses of recombinent human insulin like growth factor 1 on glucose, lipid and leucine metabolism in man. J Clin Endocrinol Met 1992; 75: 1186-1191
41. Langford K, Nicholaides K, Miell JP. Maternal and fetal insulin like growth factors and their binding proteins in the second and third trimesters of human pregnancy. Human Reproduction 1998; 13: 1389-1393
42. Bennett A, Wilson DM, Liu F, Nagashima R, Rosenfield RG, Hintz RL. Levels of insulin like growth factors I and II in human cord blood. J Clin Endo Met 1983; 57: 609-612
43. Kajantie E, Hytinantti T, Koistinen R, et al. Markers of Type I and Type III collagen turnover, insulin like growth factors and their binding proteins in cord plasma of small premature infants: relationships with fetal growth, gestational age, preeclampsia and antenatal glucocorticoid treatment. Pediatr Res 2001; 49: 489-491
44. Skalkidou A, Petridou E, Papathoma E, et al, Determinants and consequences of major insulin like growth factor components among full term healthy neonates. Cancer Epidemiol Biomarkers Preve 2003; 12: 860-865
45. Koklu E, Kurtoglu S, Akcakus M, Yikilmaz A, Gunes T. Serum insulin like growth factor 1 (IGF-I) IGF binding protein 3 (IGFBP3) and leptin levels are related to abdominal aortic intima media thickness in macrosomic newborns. Growth Hormone IGF Res 2007; 17: 26-32.
46. Nelson SM, Freenan DJ, Sattar N, Johnstone FD, Lindsay RS. IGF- I and leptin associated with fetal HDL cholesterol at birth:examination in offspring of mothers with Type 1 diabetes. Diabetes 2007; 56: 2705-2709
47. Khosravi J, Diamandi A, Bodani U, Khaja N, Krishna R. Pitfalls of immunoassay and sample for IGF-I: comparison of different assay methodologies using fresh and stored serum samples. Clin Biochem 2005; 38: 659-666
48. Yan-Jun L, Tsushima T, Minei S, et al. Insulin Like Growth Factors (IGFs) and IGF-binding proteins (IGFBP-1, -2 and -3) in diabetic pregnancy: relationship to macrosomia. J Endocrinol 1996; 43: 221-231
49. Lindsay R, Westgate J, Beattie J, et al. Inverse changes in fetal insulin;like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Clin Endocrinol (Oxf) 2007; 66: 322-8.
50. Constancia M, Hemberger M, Highes J, et al. Placental specific IGFII is a major modulator of placental and fetal growth. Nature 2002; 417: 945-948
51. Jones J, Clemmons DR. Insulin like growth factors and their binding proteins. Endocrinol Rev 1995; 16: 3-34.
52. Bruce AL, Cheetham JE, Bolton VE, Hill NC, Scholfiels PN. Temporal changes in the expression of the insulin like growth factor II gene associated with tissue maturation in the human fetus. Development 1989; 106: 543-554
53. Kubota T, Kamadas S, Taguchi M, Aso T. Determination of insulin like growth factor 2 in feto-maternal circulation in human pregnancy. Acta Endocrinol 1992; 127: 359-365
54. Verhaeshe J, Van Herck E, can Schoubroeck D, Deprest JA, Witters I. IGF-I, IGF-II, IGF binding protein I and C-peptide in second trimester amniotic fluid are dependent on gestational age but do not predict weight at birth. Pediatr Res 1999; 46: 101-108
55. Yan-Jun L, Tsushima T, Minei S, et al. Insulin like growth factors (IGFs) and IGF-binding proteins (IGFBP-1, -2 and -3) and relationship to macrosomia. J Endoc 1996; 43: 221-231
56. Westwood M. Role of insulin like growth factor binding protein I in human pregnancy. Rev Reprod 1999; 4: 160-167
57. Koistinen R, Kalkkinen N, Huhtala ML, Seppala M, Bohn H, Rytanen EM. Placental protein 12 is a decidual protein that binds somatomedin and has an idential N terminal amino acid sequence with somatomedin binding protein from human amniotic fluid. Endocrinology 1986; 118: 1375-1378
58. Bell SC, Patel SR, Jackson JA, Waites GT. Major secretory protein of human decidualised endometrium is an insulin like growth factor binding protein. J Endocrinol 1998; 118: 317-328
59. Westwood M, Gibson JM, Davies AJ, Young RJ, White A. The phosphoryation pattern of insulin like growth factor binding protein 2 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Met 1994; 79: 1735-1741
60. Suikkari AM, Koivisto VA, Koistenen R, Seppälä M, Yki-Jarvinien H. Dose response characteristics for suppression of low molecular weight insulin like growth factor binding protein by insulin. J Clin Endocrinol Met 1989; 68: 135-140
61. Conover CA, Divertie GD, Lee PDK. Cortisol increases plasma insulin like growth factor binding protein 1 in humans. Acta Endocrinol (Copenh) 1993; 128: 140-143
62. Westwood M, Gibson JM, Williams AC, et al. Hormonal regulation of circulating insulin like growth factor binding protein 1 phosphorylation status. J Clin Endocrinol Met 1995; 80: 3520-3527
63. Guler HP, Zapf J, Schmid C, Froesch ER. Insulin like growth factors I and II in health man. Estimations of half lives and production rates. Acta Endocrinol 1989; 121: 753-758
64. Wang HS, Perry LA, Kanisus J, Iles RK, Holly JMP, Chard T. Purification and assya of insulin like growth factor binding protein 1: measurement of circulating levels throughout pregnancy. J Endocrinol 1991; 128: 161-168
65. Bhatis S, Faessen GH, Carland G, et al. A longitudinal analysis of maternal serum insulin like growth factor 1 (IGF-I) and total and non phosphorylated IGF-binding protein 1 in human pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Met 2002; 87: 1864-1870.
66. Baldwin S, Chung T, Rogers M, Chard T, Wang HS. Insulin like growth factor binding protein 1, glucose tolerence and fetal growth in human pregnancy. J Endocrinol 1993; 136: 319-325
67. Hills FA, English J, Chard T. Circulating levels of IGF-I and IGF- binding protein throughout pregnancy: relation to birth weight and maternal weight. J Endocrinol 1996; 148: 303-309
68. Tisi DK, Liu XJ, Wykes LJ, Skinner CD, Koski KG. Insulin like growth factor II and binding proteins 1 and 3 from second trimester human amniotic fluid are associated with infant birth weight. J Nutr 2005; 135: 1667-1672
69. Krampl E, Kametas N, Mc Auliffe F, Campbell S, Nicholaides K. Serum insulin like growth factor binding protein 1 in pregnancy at high altitude. Obstetrics and Gynaecology 2002; 99: 765-769
70. Holly JM, Biddle Combe RA, Dunger DB, et al. Circadian variation of GH independent IGF binding protein in diabetes and its relationship to insulin: a new role for insulin? Clin Endocrinol 1988; 29: 667-675
71. Gibson JM, Westwood M, Lauszuz FF, Klebe JG, Flyvberg A, White A. Phosphorylated insulin like growth factor 1 is increased in pregnant diabetic subjects. Diabetes Care 1999; 48: 321-326
72. Loukovaara M, Leinonen P, Teramo K, Nurminen E, Andersson S, Rutanen EM. Effect of maternal diabetes on phosphorylation of insulin like growth factor binding protein 1 in cord serum. Diabet Med 2005; 22: 434-439
73. Loukovaara S, Kaaja RJ, Koistinen RA. Cord serum insulin like growth factor binding protein-1 and -3: effect of maternal diabetes and relationships to fetal growth. Diabetes Metab 2005; 31: 163-167
74. Holmes RP, Holly J, Soothill PW. Maternal serum insulin like growth factor binding protein -2 and -3 and fetal growth. Hum Reprod 1999; 14: 1879-1884
75. Hughes SC, Johnson MR, Heinrick G, Holly JM. Could abnormalities in inulin like growth factors and their binding proteins during pregnancy result in gestational diabetes? J Endocrinol 1995; 147: 517-524
76. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749
77. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815-3819
78. Esposito PA, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomised trial. J Am Med Assoc 2003; 289: 1799-1804
79. Yamamoto Y, Hirose H, Saito I, et al. Correlation of the adipose derived protein adiponectin with the insulin resistance index and serum high density lipoprotein cholesterol, independent of body mass index in the Japanese population. Clin Sci (Lond) 2002; 103: 137-142
80. Kissebah AH, Sonnenberg GE, Myklebust J, et al. Quantitative trait loci on choromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 2000; 97: 14478-14483
81. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kD adipocyte complement-related protein increases fatty acid oxidation and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 2005-2010
82. Yamauchi T, Karon J, Wali H, Terauchi Y, Kubota N, Hara K. The at derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946
83. Daimon M, Oizumi T, Saitoh, et al. Decreased serum levels of adiponectin are a risk factor for the progression to Type 2 diabetes in the Japanese population: the Fungata study. Diabetes Care 2003; 26: 2015-2020
84. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-58
85. Snehlaltha C, Kroke A, Mohlig M. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226-228
86. Yamauchi KJ, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilisation and fatty acid oxidation by achieving AMP activated protein kinase. Nat Med 2002; 8: 1288-1295
87. Shen YY, Charlesworth JA, Kelly JA, Loi KW, Peake PW. Up regulation of adiponectin, its isoforms and receptors in end stage kidney disease. Nephrol Dial Transplant 2007; 22: 171-178
88. Delporte ML, Brichard SM, Hermens MP, Beguin C, Lampert M, Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) 2003; 58: 22-29
89. Lindstorm T, Hedman CA, Flyvberg A, Arnqvist HJ. Elevated circulating adiponectin in Type 1 diabetes mellitus is associated with long diabetes duration. Clin Endocrinol (Oxf) 2006; 65: 776-782
90. Hotta K, Funahashi T, Artia Y, Takahashi M, Matsuda M, Okamoto Y. Plasma concentrations of a novel, adipose specific protein, adiponectin, in type 2 diabetic patients. Arteroscler Throm Vasc Biol 2000; 20: 1595-1599
91. Lindsay RS, Walker JD, Havel PJ, et al. Adiponectin is present in cord blood but unrelated to birth weight. Diabetes Care 2003; 26: 2244-2249
92. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Crevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004; 83: 341-347
93. Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V. Maternal and fetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endo 2007; 66: 447-453
94. Retnakaran R, Haugen F, Raif N, Connelly P, Sermer M, Zinman B. Reduced Adiponectin Concentration in Women with Gestational Diabetes. Diabetes Care 2004; 27: 799-800.
95. Williams M, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy D. Plasma adiiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 2306-2311 (Pubitemid 38619868)
96. Winzer C, Wagner O, Festa A, et al. Plasma Adiponectin, Insulin Sensitivity and Subclinical inflammation in women with Prior gestational diabetes mellitus. Diabetes Care 2004; 27: 1721-1727
97. Lonqvist F, Arner P, Nordford L, Schalling M. Overexpression of the obese (ob) gene in adipose tissuew of human obese subjects. Nat Med 1995; 1: 950-953
98. Considine R, Sinha MK, Heiman ML, et al. Serum Immunoreactive leptin concentrations in normal weight and obese humans. NEJM 1996; 334: 292-295
99. Campfield LA, Smith FJ, Guisez Y, Devos R, Burns P. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995: 269: 546-549
100. Rink T. In search of a satiety factor. Nature 1994; 372: 406-407
101. The hypothalamic-pituitary-adrenal-adipose axis. 10th International Congress of Endocrinology; 1996: San Francisco, CA.
102. Stephens TW, Basinski M, Bristow PK. The role of neuropeptide Y in the anitobesity action of the obese gene product. Nature 1995; 377: 530-532
103. Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD. Gender differences in plasma leptin concentrations. Nat Med 1996; 2: 949-950
104. Matsuda J, Yokoto I, Iida M, et al. Serum leptin concentrations in cord blood: relationship to birth weight and gender. J Clin Endocrinol Metab 1987; 82: 1642-1644
105. Sattar GI, Greer IA, Pirwani I, Gibson J, Wallace AM. Leptin levels in pregnancy: marker for fat accumulation and mobilisation? Acta Obstet Gynecol Scand 1998; 77: 278-283
106. Linnemann MA, Malek A, Sagar R, Blum WF, Schneider H, Fusch C. Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab 2000; 85: 4298-4301
107. Geary M, Herschkovitz R, Pringle PJ, Rodeck CH, Hindsmarsh PC. Ontogeny of serum leptin concentration in the human. Clin Endocrinol (Oxf) 1999; 51: 189-192
108. Le Percq J, Challer JC, Guerre-Millo M, Cauzac M, Vidal H, Hauquel-de Mouzon S. Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J Clin Endocrinol Metab 2001; 86: 2409-2413
109. Schubring C, Keiss W, Englao P, et al. Levels of leptin in maternal serum, amniotic fluid and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab 1997; 82: 1480-1483
110. Hellend IB, Reseland JE, Saugstad CD, Drevon CA. Leptin levels in pregnant women and newborn infants: gender differences and reduction during the neonatal period. Pediatrics 1998; 101: E12.
111. Maffefi M, Volpe L, Di Cianni G, et al. Plasma leptin levels in newborns from normal and diabetic pregnancies. Horm Metab Res 1998; 30: 575-580
112. Inoue M, Itabashi K, Nakano Y, Tobe T. High molecular weight adiponectin and leptin levels in cord blood are associated with an thropomorphometric measurements at birth. Horm Red 2008; 70: 268-272
113. Kayemba-Kay's S, Geary MP, Pringle J, Rodeck CH, Kingdom JC, Hindmarsh PC. Gender, smoking during pregnancy influence cord leptin concentrations in newborn infants. Eur J Endocrinol 2008; 59: 217-224
114. Vela-Huertya MM, San Vicente-Santoscoy EU, Guizar-Mendoza JM, Amador-Licona N, Aldana-Valenzula C, Hernnandez J. Leptin, insulin and glucose serum levels in large for gestational age infants of diabetic and non-diabetic mothers. J Pediatr Endocrinol Metab 2008; 21; 17-22.
115. Le Percq J, Cauzac M, Lahlou N, et al. Over expression of placental leptin in diabetic pregnancy. Diabetes Care 1998; 47: 847-850
116. Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. AJOG 2006; 194: 1537-1545
117. Persson B, Westgren M, Celsi G, Nord E, Ortqvist E. Leptin concentrations in cord blood in normal newborn infants and offspring of diabetic mothers. Horm Metab Res 1999; 31: 447-467
118. Maghbooli Z, Hossein-Nezhad A, Rahmani M, Shafaei AR, Larijani B. Relationship between leptin concentration and insulin resistance. Horm Metab Res 2007; 39: 903-907
119. Jaber SM. Metablic hormones profile in 2 week old healthy infants of diabetic mothers. Saudi Med J 2006; 27: 1338-1345
120. Koklu E, Kurtoglu S, Akcakus M, Yikilmaz A, Gumes T. Serum insulin like growth factors 1 (IGF-I), IGF binding protein 3 (IGFBP-3) and leptin levels are related to abdominal aortic intima media thickness in macrosomic infants. Growth Hormone IGF Res 2007; 17: 26-32.
121. Vlea-Huerta M, San-Vicente Santoscoy EU, Guizar-Mendoza JM, Amador-Licona N, Aldana-Valenzuela C, Hernnandez J. Leptin, insulin and glucose serum levels in large for gestational age infants of diabetic and non diabetic mothers. J Pediatr Endocrinol Metab 2008; 21: 17-22.
122. Buchanan TA, Metzeger BE, Freinkel N, Bergman RN. Insulin sensitivity and beta cell responsiveness in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. AJOG 1990; 162: 1008-1014
123. Ryan E. Hormones and insulin resistance during pregnancy. Lancet 2003; 362: 1777-1778
124. Ryan EA, Enns L. Roles of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1988; 67: 341-347
125. Catalano P, Tyzbir E, Roman N, Amini S, Sims E. Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynaecol 1991; 165: 1667-1672
126. Hiden U, Maier A, Bilban M, et al. Insulin control of placental gene expression shifts from mother to fetus over the course of pregnancy. Diabetologia 2006; 49: 123-131
127. Hay WW, Meznarich HK. Effect of maternal glucose concentration on uteroplacental glucose consumption and transfer in pregnant sheep. Proc Soc Exp Biol Med 1988; 190: 63-69
128. Pedersen J. The Pregnant Diabetic and her Newborn. 2nd edition. Munksgaard: Copenhagen, Williams & Wilkins: Baltimore 1977.
129. Molsted-Pedersen L. The Pedersen legacy. Chapter 3 in Textbook of Diabetes and Pregnancy. 2nd Edition. Eds: Hod M, Jovanovic L, Di Renzo GC, De Leiva A, Langer O. Informa Healthcare 2008.
130. HAPO Study Cooperative Research Group. Hyperglycamia and Adverse Pregnancy Outcomes. N Engl J Med 2008; 358: 1991-2002.
131. Ong K, Kratzsch J, Keiss W, Apspac study team, Costello M, Scott C, Dunger D. Size at Birth and Cord Blood Levels of Insulin, Insulin-Like Growth Factor 1 (IGF-I), IGF-2, IGF-Binding Protein- 1 (IGFBP-1), IGFBP-3, and the Soluble IGF-2/Mannose-6- phosphate receptor in term human infants. J Clin Endocrinol Metab 2000; 85: 4266-4269
132. Ng P, Lee C, Lam C, Chan I, Wong E, Fok T. Resistin in preterm and term newborns: Relation to Anthropometry, Leptin and Insulin. Pediatr Res 2005; 58: 725-730 (Pubitemid 41368904)
133. Steel JM, Johnstone FD, Hume R, Mao JH. Insulin requirements during pregnancy in women with type 1 diabetes. Obstet Gynecol 1994; 83: 253-258
134. Fuglsang J, Lauszua F, Fisker S, Flyvbjerg A, Ovesen. Growth hormone binding protein and maternal body mass index in relation to placental growth hormone and insulin requirements during pregnancy in type 1 diabetic woman. Growth Hormone IGF Res 2005; 15: 223-230
135. Bjorklund AO, Adamson UK, Carlstrom KA, et al. Placental hormones during induced hypoglycaemia in pregnant women with insulin dependent diabetes mellitus: evidence of an active role for placenta in hormonal counter regulation. BJOG 1998; 105: 649.
136. Lepercq J, Taupin P, Dubois-la Forgue D, et al. Heterogeneity of fetal growth in Type 1 Diabetic pregnancy. Diabetes Metab 2001; 27: 339-344 (Pubitemid 32625387)
137. Lepercq J, Cauzac M, Lahlou N, et al. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 1998; 47: 847-850
138. Alonso A, Del RC, Navarro A, Tolivia J, Gonzalez C. Effects of gestational diabetes mellitus on proteins implicated in insulin signaling in human placenta. Gynecol Endocrinol 2006; 22: 526-535
139. Baptiste-Roberts K, Barone BB, et al. Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. 2009; 122: 207-214
140. Coutant R, Boux de Casson F, Douay O, et al. Relationships between placental GH concentration and maternal smoking, newborn gender and maternal leptin: possible implications for birth weight. J Clin Endocrinol Metab 2001; 86: 4854-4859
141. Kolaczynski J, Nyce M, Considine R, et al. Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 1996; 45: 699-701.
142. Christou H, Connors JM, Ziotopoulou M, et al. Cord blood leptin and insulin like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab 2001; 86: 935-938